Novo Nordisk Aktie
47,48
EUR
-0,43
EUR
-0,89
%
46,75
EUR
-1,29
EUR
-2,68
%
Werbung
Novo Nordisk Aktie Analyse
19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
07.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.07.25 | Novo Nordisk Buy | UBS AG | |
18.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
16.07.25 | Novo Nordisk Buy | UBS AG | |
11.07.25 | Novo Nordisk Buy | UBS AG | |
09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
03.07.25 | Novo Nordisk Buy | UBS AG | |
01.07.25 | Novo Nordisk Buy | UBS AG | |
30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
30.06.25 | Novo Nordisk Buy | UBS AG | |
24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.06.25 | Novo Nordisk Buy | UBS AG | |
23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.06.25 | Novo Nordisk Buy | UBS AG | |
17.06.25 | Novo Nordisk Buy | UBS AG | |
16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.06.25 | Novo Nordisk Buy | UBS AG | |
09.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
02.06.25 | Novo Nordisk Buy | UBS AG | |
02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
19.05.25 | Novo Nordisk Buy | UBS AG | |
19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
09.05.25 | Novo Nordisk Buy | UBS AG | |
08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.05.25 | Novo Nordisk Buy | UBS AG | |
07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Werbung
Werbung